This is a randomized double-blind clinical trial. Potential subjects will be identified by members of the Center for Urogynecology and Pelvic Reconstructive Surgery at the Cleveland Clinic main campus. Eligible patients that agree to participate will be provided written informed consent administered by the collaborators listed on the IRB at the Cleveland Clinic main campus.